CHRISTY GOFORTH: Open Payments
NPI 1548727522 · COVINGTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 50 payments from 7 companies in 2025. Trend: 2023 $589 · 2024 $740 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $299 |
| Janssen Pharmaceuticals, Inc | 12 | $220 |
| Alkermes, Inc. | 10 | $194 |
| ABBVIE INC. | 4 | $102 |
| Otsuka America Pharmaceutical, Inc. | 5 | $87 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: CAPLYTA, INVEGA SUSTENNA, ARISTADA, VRAYLAR, REXULTI, INVEGA TRINZA, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across TN — which companies pay providers there.
